NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-316-2007-0-US-01 Novel Natural Product Inhibitors Of ABCG2 From The Developmental Therapeutics Program Compound Collection US 60/986,155 Abandoned
NCI E-208-2006-0-PCT-03 INFLUENZA VIRUS NUCLEIC ACID MICROARRAY AND METHOD OF USE PCT PCT PCT/US07/023448 Expired
NHLBI E-257-2005-0-US-04 Wide-Area Fluorescence Detection System For Multi-Photon Microscopy US CON 11/979,600 7667210 Issued PDF
NCI E-226-2006-0-PCT-02 METHOD OF PREPARING MACROMOLECULAR CONTRAST AGENTS AND USES THEREOF PCT PCT PCT/US2007/083734 Expired
NCI E-256-2006-0-PCT-02 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs PCT PCT PCT/US2007/083772 Expired
NCI E-256-2006-0-EP-06 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs EP National Stage 07868671.4 Abandoned
NCI E-256-2006-0-CA-04 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs CA National Stage 2668638 Abandoned
NCI E-256-2006-0-IN-07 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs IN National Stage 2947/DELNP/2009 Abandoned
NCI E-256-2006-0-AU-03 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs AU National Stage 2007316416 Abandoned
NCI E-139-2007-0-US-06 Methods And Compositions For Detecting Immune Responses US ORD 11/913,583 8703484 Abandoned PDF
NCI E-328-2007-0-US-01 Identification Of Persons Likely To Benefit From Statin Mediated Colon Cancer Prevention By Pharmacogenetics US 60/985,587 Abandoned
NICHD E-273-2007-0-US-01 METHODS AND APPARATUSES FOR ESTIMATING THE ELLIPTICAL CONE OF UNCERTAINTY US 60/996,169 Abandoned
NHGRI E-009-2007-0-PCT-02 COMPOSITIONS AND METHODS FOR PREDICTING BODY SIZE IN DOGS PCT PCT PCT/US2007/083496 Expired
NHLBI E-099-2008-0-US-01 Tandem L2 Fusion Vaccines For Prevention Of Human Papillomavirus Infection US 61/001,630 Abandoned
NCI E-050-2007-2-AU-02 MicroRNA expression signature for predicting survival and metastases in Hepatocellular carcinoma AU National Stage 2007314212 Abandoned
NCI E-050-2007-2-JP-05 MICRORNA EXPRESSION SIGNATURE FOR PREDICTING SURVIVAL AND METASTASES IN HEPATOCELLULAR CARCINOMA JP National Stage 2009-535366 Abandoned
NCI E-050-2007-2-EP-04 MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) EP National Stage 07867402.5 Abandoned
NCI E-050-2007-2-CH-10 MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) CH EP 07867402.5 Abandoned
NCI E-050-2007-2-GB-12 MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) GB EP 07867402.5 Abandoned
NCI E-050-2007-2-IT-13 MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) IT EP 07867402.5 Abandoned
NCI E-050-2007-2-FR-11 MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) FR EP 07867402.5 Abandoned
NICHD E-043-1999-0-US-08 Utergolobin in The Treatment of IgA Meditated Nephropathy US CON 11/934,050 8084415 Abandoned PDF
NCI E-050-2007-2-PCT-01 Identification Of Novel Liver Cancer Biomarkers From MicroRNA Profiling PCT PCT COMB PCT/US2007/023660 Expired
NCI E-050-2007-2-CA-03 Identification Of Novel Liver Cancer Biomarkers From MicroRNA Profiling CA National Stage 2667617 Abandoned
NCI E-021-2001-0-US-10 Chromosome 3p21.3 Genes Are Tumor Suppressors US CON 11/932,724 7977468 Expired PDF
NCI E-057-1994-2-US-10 MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS US DIV 11/932,255 7803614 Expired PDF
NCI E-315-2003-0-US-03 SH2 Domain Binding Inhibitors US ORD 11/932,424 7767645 Abandoned PDF
NCI E-057-1994-2-US-08 MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS US DIV 11/932,826 7763586 Expired PDF
NCI E-057-1994-2-US-07 MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS US DIV 11/932,406 7749719 Expired PDF
NCI E-057-1994-2-US-09 MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS US CON 11/932,338 7745212 Expired PDF
NCI E-014-2007-0-HK-07 SMOOTHENED POLYPEPTIDES AND METHODS OF USE HK National Stage 10104791.1 Abandoned
NCI E-014-2007-0-MY-13 SMOOTHENED POLYPEPTIDES AND METHODS OF USE MY National Stage PI20091748 Abandoned
NHGRI E-324-2001-1-US-02 SELECTIONS OF GENES AND METHODS OF USING THE SAME FOR DIAGNOSIS AND FOR TARGETING THE THERAPY OF SELECT CANCERS. US CON 11/981,502 8263759 Abandoned PDF
NHGRI E-324-2001-0-US-02 METHODS FOR ANALYZING HIGH DIMENSIONAL DATA FOR CLASSIFYING DIAGNOSING PROGNOSTICATING AND/OR PREDICTING DISEASES AND OTHER BIOLOGICAL STATES US CON 11/928,901 7783431 Abandoned PDF
NCI E-014-2007-0-PCT-02 SMOOTHENED POLYPEPTIDES AND METHODS OF USE PCT PCT PCT/US2007/083027 Expired
NCI E-207-2007-2-US-01 N4 Modification Of Nucleotides For Increased Stability, Oral Boavailability, Targeted Delivery And Combination Therapy US ORD 11/929,556 Abandoned
NIAID E-168-2004-0-US-04 Linking Malarial Proteins To OMPC Greatly Increases The Antibody Response To The Protein US National Stage 11/919,610 Abandoned
NCI E-014-2007-0-EP-20 SMOOTHENED POLYPEPTIDES AND METHODS OF USE EP DIV 11179413.7 Abandoned
NCI E-014-2007-0-IN-09 SMOOTHENED POLYPEPTIDES AND METHODS OF USE IN National Stage 815/MUMNP/2009 Abandoned
NCI E-014-2007-0-EP-06 SMOOTHENED POLYPEPTIDES AND METHODS OF USE EP National Stage 07871292.4 Abandoned
NIDA E-230-2007-0-US-01 (+)-Opioids and Methods of Use US 60/983,927 Abandoned
NIDA E-077-2016-0-US-01 TRICYCLIC COMPOUNDS AND METHODS FOR USING THE SAME US 60/983,929 Abandoned
NIDA E-076-2016-0-US-01 TLR MODULATORS AND METHODS FOR USING THE SAME US 60/983,924 Abandoned
NCI E-021-2001-0-US-12 Chromosome 3p21.3 Genes Are Tumor Suppressors US CON 11/929,559 Abandoned
NCI E-014-2007-0-AU-03 SMOOTHENED POLYPEPTIDES AND METHODS OF USE AU National Stage 2007329678 Abandoned
NCI E-014-2007-0-CA-04 SMOOTHENED POLYPEPTIDES AND METHODS OF USE CA National Stage 2667821 Abandoned
NCI E-029-2008-0-US-01 HPV Injection Interrupts Expression Of Cellular Tumor Suppressive MiR-34alpha US 60/983,368 Abandoned
NIMH E-157-2006-1-US-02 Methods To Identify Patients At Risk Of Developing Adverse Events During Treatment With Antidepressant Medication US ORD 11/925,334 7906283 Abandoned PDF
NIMH E-157-2006-1-PCT-01 Methods To Identify Patients At Risk Of Developing Adverse Events During Treatment With Antidepressant Medication PCT PCT PCT/US2007/082683 Expired
NIDDK E-104-1989-0-US-19 BIOLOGICALLY ACTIVE SYNTHETIC THYROTROPIN AND CLONED GENE FOR PRODUCING SAME US CON 11/977,791 Abandoned